Reuters logo
a year ago
BRIEF-Indivior says U.S. FDA grants fast track designation for drug for opioid use disorder
May 26, 2016 / 4:41 PM / a year ago

BRIEF-Indivior says U.S. FDA grants fast track designation for drug for opioid use disorder

May 26 (Reuters) - Indivior Plc :

* Today announced that U.S. FDA has granted fast track designation for RBP-6000 buprenorphine monthly depot

* Fast track designation is granted to facilitate and expedite development and review for drugs Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 80 6749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below